{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:06:52Z","timestamp":1791515212481,"version":"4.3.4"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T00:00:00Z","timestamp":1458000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0151511","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T17:45:22Z","timestamp":1458063922000},"page":"e0151511","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":214,"title":["Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction"],"prefix":"10.1371","volume":"11","author":[{"given":"Chikara","family":"Komiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoichiro","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Shiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsaku","family":"Furuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Shimazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"L Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","article-title":"National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants","volume":"377","author":"MM Finucane","year":"2011","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"SE Kahn","year":"2006","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"N Sarwar","year":"2010","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"SR Seshasai","year":"2011","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"ME Rinella","year":"2015","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1210\/jc.2012-3093","article-title":"Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications","volume":"98","author":"G Targher","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jhep.2011.06.010","article-title":"Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review","volume":"56","author":"C Thoma","year":"2012","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrd3180","article-title":"SGLT2 inhibition\u2014a novel strategy for diabetes treatment","volume":"9","author":"EC Chao","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pharmthera.2013.04.003","article-title":"Ipragliflozin and other sodium-glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data","volume":"139","author":"E Kurosaki","year":"2013","journal-title":"Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/dom.12054","article-title":"Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise","volume":"15","author":"K Stenlof","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2337\/dc15-0355","article-title":"Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition","volume":"38","author":"G Ferrannini","year":"2015","journal-title":"Diabetes Care"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/oby.2012.59","article-title":"Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats","volume":"20","author":"JJ Devenny","year":"2012","journal-title":"Obesity"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejphar.2013.05.014","article-title":"Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice","volume":"715","author":"A Tahara","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13098-015-0102-8","article-title":"Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus","volume":"7","author":"S Qiang","year":"2015","journal-title":"Diabetol Metab Syndr"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/ATVBAHA.114.303034","article-title":"Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease","volume":"34","author":"CD Byrne","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1194\/jlr.M800019-JLR200","article-title":"Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice","volume":"49","author":"I Murano","year":"2008","journal-title":"J Lipid Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1038\/ncomms5982","article-title":"Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosis","volume":"5","author":"M Tanaka","year":"2014","journal-title":"Nat Commun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","article-title":"Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans","volume":"46","author":"S Cinti","year":"2005","journal-title":"J Lipid Res"},{"key":"ref20","article-title":"Tofogliflozin improves insulin resistance in skeletal muscle and accelerates lipolysis in adipose tissue in male mice","author":"A Obata","year":"2015","journal-title":"Endocrinology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jceh.2015.02.005","article-title":"Remogliflozin etabonate improves fatty liver disease in diet-induced obese male mice","volume":"5","author":"S Nakano","journal-title":"J Clin Exp Hepatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e0116851","DOI":"10.1371\/journal.pone.0116851","article-title":"Beneficial effects of canagliflozin in combination with pioglitazone on insulin sensitivity in rodent models of obese type 2 diabetes","volume":"10","author":"Y Watanabe","year":"2015","journal-title":"PLOS ONE"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2011.06.002","article-title":"Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways","volume":"14","author":"JL Yecies","year":"2011","journal-title":"Cell Metab"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"31069","DOI":"10.1074\/jbc.M003335200","article-title":"Sterol regulatory element-binding protein-1 is regulated by glucose at the transcriptional level","volume":"275","author":"AH Hasty","year":"2000","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2337\/diabetes.53.3.560","article-title":"Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice","volume":"53","author":"T Matsuzaka","year":"2004","journal-title":"Diabetes"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"19353","DOI":"10.1074\/jbc.M201584200","article-title":"Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)\/Lep(ob) mice","volume":"277","author":"N Yahagi","year":"2002","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1172\/JCI27300","article-title":"Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2","volume":"116","author":"DB Savage","year":"2006","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.2337\/db07-0767","article-title":"Adipocyte death, adipose tissue remodeling, and obesity complications","volume":"56","author":"KJ Strissel","year":"2007","journal-title":"Diabetes"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1128\/MCB.01300-08","article-title":"Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI","volume":"29","author":"T Khan","year":"2009","journal-title":"Mol Cell Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"A Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.1038\/ncomms8906","article-title":"Selective enhancement of insulin sensitivity in the mature adipocyte is sufficient for systemic metabolic improvements","volume":"6","author":"TS Morley","year":"2015","journal-title":"Nat Commun"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1074\/jbc.M411863200","article-title":"The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species","volume":"280","author":"Y Lin","year":"2005","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI72227","article-title":"Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients","volume":"124","author":"E Ferrannini","year":"2014","journal-title":"J Clin Invest"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI70704","article-title":"Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production","volume":"124","author":"A Merovci","year":"2014","journal-title":"J Clin Invest"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nm.3828","article-title":"Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion","volume":"21","author":"C Bonner","year":"2015","journal-title":"Nat Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/er.2006-0026","article-title":"The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications","volume":"28","author":"BE Dunning","year":"2007","journal-title":"Endocr Rev"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0140-6736(13)60683-2","article-title":"Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial","volume":"382","author":"WT Cefalu","year":"2013","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/dom.12459","article-title":"Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data","volume":"17","author":"S Del Prato","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.14740\/jocmr2417w","article-title":"Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes: interim outcome of the ASSIGN-K study","volume":"8","author":"T Iizuka","year":"2016","journal-title":"J Clin Med Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0140-6736(10)60407-2","article-title":"Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial","volume":"375","author":"CJ Bailey","year":"2010","journal-title":"Lancet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.cmet.2015.09.026","article-title":"Neuronal Regulation of Energy Homeostasis: Beyond the Hypothalamus and Feeding","volume":"22","author":"MJ Waterson","year":"2015","journal-title":"Cell Metab"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0151511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T17:45:43Z","timestamp":1540230343000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0151511"}},"subtitle":[],"editor":[{"given":"Takahisa","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,15]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0151511","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,15]]}}}